Pulmonary Delivery of Linezolid Nanoparticles for Treatment of Tuberculosis: Design, Development, and Optimization
Author:
Funder
Gujarat Council of Science and Technology
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science
Link
https://link.springer.com/content/pdf/10.1007/s12247-020-09491-9.pdf
Reference54 articles.
1. Global tuberculosis report. World Health Organization 2018. Report No.: 9781315254227.
2. Global tuberculosis report. World Health Organization 2019.
3. Sosnik A, Carcaboso ÁM, Glisoni RJ, Moretton MA, Chiappetta DA. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery. Adv Drug Deliv Rev. 2010;62(4–5):547–59. https://doi.org/10.1016/j.addr.2009.11.023.
4. Kaur M, Garg T, Rath G, Goyal AK. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst. 2014;31(1):49–88. https://doi.org/10.1615/critrevtherdrugcarriersyst.2014008285.
5. Sotgiu G, Centis R, D'Ambrosio L, Castiglia P, Migliori GB. Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains. Eur Respir J. 2014;45(1):287–9. https://doi.org/10.1183/09031936.00135014.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chitosan-Based Nanocarriers for Pulmonary and Intranasal Drug Delivery Systems: A Comprehensive Overview of their Applications;Current Drug Targets;2024-05
2. Investigation of Methicillin-resistant Staphylococcus aureus inhibition with gallic acid and linezolid loaded Poly(Ɛ-caprolactone)-Collagen-Xylitol carrier;Process Biochemistry;2023-11
3. Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery;Polymers;2023-09-21
4. Harnessing the power of PLA-PEG nanoparticles for Linezolid delivery against methicillin-resistant Staphylococcus aureus;International Journal of Pharmaceutics;2023-07
5. Ciprofloxacin HCl-loaded Albumin Nanoparticles for the Treatment of Recurrent Urinary Tract Infections: Preparation, Optimization, and Evaluation of Antibacterial Activity;Journal of Pharmaceutical Innovation;2023-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3